Education
About Us
Working with TipRanks
Follow Us
Anebulo Pharmaceuticals, Inc. (ANEB)
:ANEB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -8.31M | $ -11.78M | $ -6.83M | $ -3.61M | $ -173.35K |
| EBITDA | $ -8.05M | $ -11.78M | $ 5.55K | $ -30.24M | $ -173.35K |
| Net Income | $ -8.20M | $ -11.73M | $ -6.83M | $ -30.25M | $ -174.64K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.09M | $ 11.25M | $ 14.55M | $ 19.99M | $ 3.02M |
| Total Assets | $ 4.07M | $ 11.67M | $ 15.58M | $ 21.65M | $ 3.03M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 201.29K |
| Net Debt | $ -3.09M | $ -11.25M | $ -14.55M | $ -19.99M | $ -2.82M |
| Total Liabilities | $ 260.58K | $ 1.07M | $ 512.53K | $ 241.63K | $ 3.20M |
| Stockholders' Equity | $ 3.81M | $ 10.60M | $ 15.07M | $ 21.41M | $ -171.14K |
| Cash Flow | |||||
| Free Cash Flow | $ -8.09M | $ -9.68M | $ -5.44M | $ -4.87M | $ -150.77K |
| Operating Cash Flow | $ -8.09M | $ -9.68M | $ -5.44M | $ -4.87M | $ -150.77K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ -62.35K | $ 6.38M | $ 0.00 | $ 21.83M | $ 3.18M |